X-71224365-C-T
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_000166.6(GJB1):c.658C>T(p.Arg220*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000902 in 110,878 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000166.6 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Charcot-Marie-Tooth disease X-linked dominant 1Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia, ClinGen, Labcorp Genetics (formerly Invitae)
- X-linked progressive cerebellar ataxiaInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GJB1 | NM_000166.6 | c.658C>T | p.Arg220* | stop_gained | Exon 2 of 2 | ENST00000361726.7 | NP_000157.1 | |
| GJB1 | NM_001097642.3 | c.658C>T | p.Arg220* | stop_gained | Exon 2 of 2 | NP_001091111.1 | ||
| GJB1 | NM_001440770.1 | c.658C>T | p.Arg220* | stop_gained | Exon 3 of 3 | NP_001427699.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GJB1 | ENST00000361726.7 | c.658C>T | p.Arg220* | stop_gained | Exon 2 of 2 | 1 | NM_000166.6 | ENSP00000354900.6 |
Frequencies
GnomAD3 genomes AF: 0.00000902 AC: 1AN: 110878Hom.: 0 Cov.: 21 show subpopulations
GnomAD4 exome Cov.: 32
GnomAD4 genome AF: 0.00000902 AC: 1AN: 110878Hom.: 0 Cov.: 21 AF XY: 0.00 AC XY: 0AN XY: 33080 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
Age Distribution
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease X-linked dominant 1 Pathogenic:3Uncertain:1Other:1
- -
PVS1_Str, PS3_Str, PS4_Str, PP3_M -
Variant interpreted as Pathogenic and reported on 10-28-2019 by Lab Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. -
- -
- -
not provided Pathogenic:3
- -
Published functional studies demonstrate incomplete channel assembly and significantly reduced currents (Nualart-Marti et al., 2013; Castro et al., 1999); Nonsense variant predicted to result in protein truncation in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 8737658, 7477983, 8958325, 21871435, 11571214, 30042657, 25025039, 9401007, 8076700, 24123415, 27228968, 16442804, 10234007, 23587648, 8816997, 9592087, 8162049, 21291455, 28448691, 27844031, 31211173, 30881289, 9364054, 29077882, 34429228, 37284795) -
- -
Inborn genetic diseases Pathogenic:1
The p.R220* pathogenic mutation (also known as c.658C>T), located in coding exon 1 of the GJB1 gene, results from a C to T substitution at nucleotide position 658. This changes the amino acid from an arginine to a stop codon within coding exon 1. This stop codon occurs at the 3' terminus of GJB1 and is not expected to trigger nonsense-mediated mRNA decay; however, it impacts the last 64 amino acids and removes approximately 23% of the protein. This alteration has been detected in multiple patients and families with X-linked dominant Charcot-Marie-Tooth disease and has been shown to co-segregate with disease (Fairweather N et al. Hum. Mol. Genet., 1994 Jan;3:29-34; Ionasescu VV. Cell Biol. Int., 1998 Nov;22:807-13; Tsai PC et al. Ann Clin Transl Neurol, 2016 11;3:854-865). Functional studies have demonstrated protein mislocalization and altered gap junction channel activity (Tsai PC et al. Ann Clin Transl Neurol, 2016 11;3:854-865; Ressot C et al. J. Neurosci., 1998 Jun;18:4063-75; Carrer A et al. Hum. Mol. Genet., 2018 01;27:80-94). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
Charcot-Marie-Tooth Neuropathy X Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg220*) in the GJB1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 64 amino acid(s) of the GJB1 protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with X-linked dominant Charcot-Marie-Tooth disease (PMID: 7477983, 8162049, 9364054, 21291455). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 10435). Algorithms developed to predict the effect of variants on gene product structure and function are not available or were not evaluated for this variant. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on GJB1 function (PMID: 8816997, 9364054, 9592087). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at